Vimta Labs Limited
VIMTALABS · 524394 · Healthcare · Healthcare Research, Analytics & Technology
Rs 600.3+8.9 (+1.50%)
- Market cap
- Rs 1,334 Cr
- P/E
- 45.03x
- P/B
- 3.89x
- 52W high / low
- Rs 774.7 / Rs 376.05
P/E, P/B and ROE are inconsistent: ROE x P/E = 9.19 but P/B = 3.89 (> 25% apart); one input is likely on a different basis.
More
Peer comparison
Official BSE basic industry: Healthcare Research, Analytics & Technology. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Suven Life Sciences Limited | Rs 320.2 | Rs 8,453 Cr | Rs 29.7 Cr | Rs -352.4 Cr | — | -100.50% |
| Vimta Labs LimitedThis company | Rs 600.3 | Rs 1,334 Cr | Rs 339 Cr | Rs 61.4 Cr | 45.03x | 20.41% |
| Bilcare Limited | Rs 98.67 | Rs 232 Cr | Rs 799 Cr | Rs -13.3 Cr | — | 2.33% |
| TAKE Limited | Rs 13.31 | Rs 197 Cr | Rs 92.5 Cr | Rs 12.8 Cr | 34.13x | 49.76% |
| Novelix Pharmaceuticals Ltd | Rs 70 | Rs 191 Cr | — | — | — | — |
| Jeevan Scientific Technology Ltd | Rs 85.18 | Rs 171 Cr | Rs 71.8 Cr | Rs 5.1 Cr | 29.47x | 8.40% |
| Median | Rs 342.74 | Rs 752 Cr | Rs 206 Cr | Rs 33.2 Cr | 37.25x | 14.41% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Loading stock details